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Inhibition of Supressor T -Lymphocytes by Corynebacterium parvum 
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Department of Dermatology, University of Miinster, West Germany 
Pretreatment of BALB/c mice with Corynebacterium 
parvum inhibited the induction of tolerance to the con-
tact sensitizing agent 2,4-dinitrofluorobenzene induced 
by intrayenous injection of DNBSOa• The suppressive 
effect on tolerance induction has further been analyzed 
by adoptive transfer experiments. Injection of C. parvum 
intra peritoneally (0.7-2.8 mg/mouse) before injection of 
the tolergen inhibited the generation of . T -suppressor 
cells as shown by transfer of spleen cells from the toler-
ized donor to naive recipients. Pretreatment of the recip-
ients of the suppressor T-cells from tolerized animals 
with C. parvum also inhibited the function of these cells 
in the recipient animals. Time-kinetic experiments sug-
gested that more than one mechanism appeared to be 
responsible for the tolerance induced by DNBSOa; C. 
parvum (probably via activated macrophages) sup-
pressed tolerance which is mediated by T -suppressor 
lymphocytes. These results suggest that T -suppressor 
lymphocytes may-similarly as T-helper cells-be mod-
ulated by an activated monocytic-phagocytic system. 
The induction phase of contact allergy is characterized by 
cell interac tions between allergen presenting macrophages and 
T-Iymphocytes which recognize the allergen and/or an allergen 
modifie~ alloantigen (la-antigen [1].) Under normal sensitiza-
tion conditions suppressor cells are also generated [2,3]. The 
immune response that developes may then be considered as a 
result of a balance between effector and suppressor elements 
[4]. Little is known of the genetic, cellular, and molecular 
requirements for the stimulation of specific T-suppressor cells. 
Some observations indicate that the mechanism of T -suppres-
sor cell stimulation may be as complex as that of T -helper cells 
[5]. Antigen specific T-helper cells are induced by macrophage-
bound antigens [1], the proliferation of these cells is modulated 
by a number of stimulatory or inhibitory factors released by 
macro phages [6,7]. ·Little is known about such an unspecific 
interaction of macrophages with T-suppressor lymphocytes in 
contact allergy or in other delayed-type hypersensitivity exper-
imental models. We have shown that pretreatment of mice with 
Corynebacterium parvum (C. parvum) enhances the immune 
response against 2,4-dinitrofluorobenzene (DNFB) [8]. Further 
analysis of this enhancement suggested that C. parvum might 
inhibit a suppressor mechanism, most likely suppressor lym-
phocytes, and by this mechanism increase the number of func-
tionally active effector lymphocytes [8]. In the following inves-
tigations we studied t)1e effect of C. parvum treatment on the 
T-suppressor cell induction by intravenous (i.v.) administration 
of 2,4-dinitrobenzenesulfonic acid (DNBSOa). It will be shown 
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that pretreatment with C. parvum inhibits the induction and 
function of T -suppressor cells in this model. 
MATERIALS AND METHODS 
Mice 
BALB/c mice were purchased from the Zentralinstitut fur Versuchs-
tierzucht, Hannover, FRG, kept under conventional conditions, and 
used at the age of 10 to 12 weeks. 
R eagents 
C. paruum (7 mg/ml lot CA 761) , heat inactivated, was obtained 
from Welcome R esearch Laboratories, Beckenham, England. 2,4-dini-
trofluorobenzene (DNFB) and 2,4-dinitrobenzenesulforuc acid 
(DNBSOJ-NA) were obtained from Sigma Chemical Co., Munchen, 
FRG. 
Sensitization and Elicitation of DNFB Contact Sensitivity 
Young adult BALB/c mice were sensitized with DNFB (15 JLl, 0.5%) 
by 2 daily paintings [8,9]. The ear was painted on the dorsum with 0.3% 
DNFB on day 5 and ear thickness measured 24 and 48 h.r later. Ear 
thickness was quantitated by using an engineers micrometer [8,9]. 
Tolerance was induced by intravenous (i.v.) injection of 15 mg of 
DNBSOJ-NA 6 days before sensitization attempts [9]. 
Preparation and Transfer of Spleen Cells 
Spleen cell suspensions were prepared from mice 6 days after i.v. 
injection of DNBSOa [10] by gentle teasing the tissue through a 60 
mesh wire screening into Dulbecco's minimum essential medium (Dul-
becco's MEM) supplemented with 10% fetal calf serum (FCS). After 
osmo-shock to lyse the contaminating erythrocytes and washing, the 
cells were counted and 0.5 ml (1 x 106 spleen cells/mouse) were injected 
immediately i.v. Two hours after injection the mice were sensitized by 
2 daily abdominal paintings of 0.5% DNFB. Four days after the last 
painting all mice were challenged on the ears with 0.3% DNFB. Twenty-
four hours la ter ear swelling was measured. 
Statistical Analysis 
All data were analyzed by a one-way analysis of variance followed by 
Scheffr e's test for least significant difference. 
RESULTS 
The experimental design is shown in Fig 1. In the first series 
of experiments (Fig la) the tolerogen (DNBSOa) and C. parvum 
were injected at the same day and the degree of tolerance 
assessed 6 days later after 2 daily applications of 0.5% DNFB. 
The results are shown in Fig 2. By increasing the dose of the 
tolerogen the degree of tolerance obtained was increased. Al-
most 100% tolerance was obtained with 15 mg DNBS03 per 
mouse, a dose usually injected to induce tolerance [10]. Treat-
ment with C. parvum generally diminished tolerance at all 
doses of the tolerogen used. 
In the next type of experiment (Fig Ib) the effect of C. 
parvum on transferable suppressor cells was investigated. 
Spleen cells from donors tolerated with 15 mg DNBS03 trans-
ferred tolerance to the recipients as shown in Fig 3. However, 
C. parvum pretreated donors did not produce sufficient func-
tionally active suppressor cells which could be transferred to 
the recipients (Fig 3). 
In the next (type C) experiments the recipients were pre-
treated with C. parvum before injection of spleen cells (sup-
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FIG 2. Reduction of tolerance by pretreatment of the mice with C. 
paruum (type a experiment) . e-----e i.v. injection of DNBSO;] and 
0--0 mice receiving C. paruum (2 .1 mg/mouse) 2 hI' before i.v. 
injection of DNBSO". The differences between the groups are statist i-
cally significant (p < 0.05) at 1.5, and 15 mg DNBSO". Negative control : 
nonsensitized mice painted on the ear with 0.3% DNFB. Positive 
control: sensitized animals challenged on the right ear with 0.3% DNFB. 
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FIG 3. C. paruum treatment of the donor of suppressor cells. Mice 
were pretreated with C.parvum (2.8 mg/ mouse) 1 week before injection 
of DNBSO" (type b experiment ). Ear swelling after sensitization and 
challenge of: A = positive control; B = mice tolerized with DNBSO,,; C 
= mice receiving spleen cells from to lerized animals; D = illice receiving 
spleen cells from dono,s pretreated with C. parVlan before tolerization; 
E = mice receiving spleen cells from donors pretreated with C. parvum 
only; F = negative control. Statistical analysis: Group C increased aver 
F (p < 0.05); Group D increased over C (p < 0.05). 
pressor cells) (Fig 4). In non-C. parvum treated recipients 
tolerance could be induced by transfer of spleen cells from 
tolerated animals, however, recipients pretreated with C. par· 
vum at the day of suppressor cell transfer or 1 week before, did 
not show any tolerance. The spleen cells transferring tolerance 
were sensitive to anti-theta serum and complement and heat-
killing, identifying these cells as T-suppressor cells. 
In Table I the effect of 2 different doses of C. parvum injected 
into the recipient at various times before suppressor cell transfer 
on suppressor cell function in the recipient is compared with its 
effect on normal contact reaction. Treatment of the recipient 
animals with 1.4 mg C. parvum at the day of ' suppressor cell 
transfer (day 0) significantly inhibited the function of the sup-
pressor cells in these animals; sensitization and elicitation of 
contact allergy in animals receiving no suppressor cells was only 
slightly affected by the C. parvum treatment. 
Injection of a higher dose of C. parvum (2.8 mg/ mouse) 
significantly inhibited contact allergy (and suppressor cell func-
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FIG 4. C. paruum treatment of the recipients of suppressor cells. 
Mice receiving spleen cells from tolerant animals were pretreated with 
C. parvum (2.8 mg/ mouse) 1 week before spleen cell transfer (type c 
experiment). Ear swelling after sensitization and challenge of: A: posi-
t ive control; B: mice treated with C. parvum 2 weeks before sensitiza-
t ion; C: mice tolerized with DNBSO" (15 mg i.v./mouse); D: mice 
receiving spleen cells fTom donors of group C; E: mice receiving anti-
theta serum and complement treated spleen cells from tolerant donors 
(group C); F: mice treated with C. paruum 1 week before injection of 
spleen cells from tolerant donors; G: negative contro!' Statistical anal -
ysis: Group D increased aver G (p < 0.05); Group E increased over D 
(p < 0.05); Group E not different from A; Group F increased over D (p 
< 0.05) ; Group F not different from A. 
TABLE I. Effect of uarious doses of C. parvum administered at 
uarious times before sensitization and suppressor cell transfer 
C. parVlIm" i.p. 
mg/ mouse 
1.4 
2.8 
2.8 
2.8 
At day 
0" 
o 
-7 
-13 
Ear swelling (10- 2 mm) ± SD in animals" 
receiving 
No ceLIs 
28.4 ± 3.5 
25.2 ± 4.2 
19.2 ± 3.7 
28.6 ± 4.1 
28.3 ± 2.8 
Suppressor ceLIs 
8.5 ± 0.7 
20.7 ± 5.7 
22.4 ± 2.6 
29.1 ± 3.1 
9.5 ± 0.7 
" Mice receiving 1 X 108 spleen cells from tolerated animals, or no 
cells were sensitized 2 hr and 1 day after suppressor cell transfer with 
15 fLl 0.5% DNFB. 
b Day of suppressor cell transfer and sensitization. 
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TABLE II. Efficiency of C. parvum treatment on tolerance induction, suppressor cell induction and function 
Effect of C. parvum on 
Tolerance (DNBS03 i.v., type a exp.) 
On suppressor cell induction (donor treated, type b exp.) 
On suppressor cell function (recipient treated, type c exp.) 
C. parvum treatmen t (2.8 mg/mouse) before tolerance-, suppressor cell 
induction or suppressor cell transfer at 
Day 0" Day-? Day- 13 Day-20 No treatment 
50-70< 85-100b 100 n.d. 100b 
10 10 15 100 100 
15" 20 100 n.d. 100 
a Day 0 = day of DNBS03 injection in type a and b experiment, day of suppressor cell transfer in type c experiment. 
b % tolerance; 100% = maximal tolerance obtained by the method used (DNBS03 i.v. or suppressor cell transfer). 
C Depending on the dose of DNBS03 used to induce tolerance (see Fig 1). 
" 1.4 mg C. paruum, i.p. 
tion) if administered at the day of sensitization. Pretreatment 
of the mice with 2.8 mg C. paruum 1 week (day 7) before 
suppressor cell transfer and/or sensitization had no effect on 
the cont~ct reaction of sensitized animals receiving no cells; the 
suppressor cell function, however, was completely inhibited. C. 
paruum administered 2 weeks (day 13) before suppressor cell 
transfer did not affect contact reaction or suppressor cell func-
tion. 
In Table II the results of C. paruum pretreatment at various 
intervals before tolerance induction, either directly by i.v. in-
jection of DNBS03 or by transfer of DNBSOa-induced suppres-
sor T -cells are summarized. Tolerance induction by intravenous 
injection of DNBS03 was significantly reduced if C. paruum 
was applied a few hours before; a slight effect could be observed 
after i.p. injection of C. paruum 6 days before tolerance induc-
tion. However, the induction of transferable functionally active 
supressor T -cells could still be significantly suppressed if C. 
paruum was injected 2 weeks before intravenous injection of 
DNBS03 (day-13). The function of the transferred suppressor 
T -cells could significantly be inhibited if C. paruum was injected 
6 days before transfer of the suppressor cells into the naive 
recipient mice. Treatment of the recipient animals with C. 
paruum 2 weeks before transfer had no inhibitory effect on the 
transferred T-suppressor cells. 
DISCUSSION 
We previously described that pretreatment of mice with C. 
paruum before sensitization with a nonoptimal dose of DNFB 
enhanced the contact allergic response [8]. Further anaIysis of 
this phenomenon pointed to a possible involvement of suppres-
sor mechanisms which were inhibited by the C. paruum treat-
ment [8]. We now studied the effect of C. parvum treatment on 
tolerance and suppressor T-cell induction by DNBSOa. Injec-
tion of DNBS03 results in the induction of T -suppressor lym-
phocytes which after transfer suppress the response in naive 
recipients to the contact allergen as shown by Phanuphak, 
Moorhead, and Claman [10]. Our results demonstrate that the 
pretreatment with C. paruum (1) reduced the tolerance ob-
tained by i.v. injection of the tolerogen, (2) inhibited the induc-
tion of functionally active suppressor lymphocytes, and (3) 
suppressed the function of T-suppressor cells in the recipient. 
The experiments measuring the inhibitory effect of C. par-
uum treatment on tolerance induction without transfer (Table 
I) as compared to the effect of C. parvum on transferable 
suppressor T-cells suggest that more than one mechanism is 
involved in tolerance to DNFB. Although C. parvum inhibited 
the induction of functionally active suppressor T-cells in the 
donor animals and the functions of suppressor cells in the 
recipient animals up to 2 weeks after injection it only showed 
significant inhibitory activity on tolerance induced by i.v. injec-
tion of DNBSOa if injected shortly before tolerogen injection. 
This suggests that, although T -suppressor cells are inhibited by 
this treatment, some kind of unresponsiveness may be obtained 
by DNBS03-injection which is not significantly influenced by 
C. parvum treatment. Such a tolerance mechanism could be 
receptor blockade of the antigen sensitive cell [11]. It may also 
be conceivable that tolerance in this model may be mediated 
by different T-cell populations as has been described with 
antigen modified syngeneic cells in the DNFB contact allergy 
system [12] and in another model of delayed-type hypersensi-
tivity using fowl gamma-globulin coupled syngeneic spleen cells 
[13]. 
Different sensitivities towards the inhibitory effect of C. 
paruum treatment of helper and suppressor cells in our model 
are suggested by the experiments shown in table I. A dose of C. 
parvum which significantly reduced suppressor cell activity had 
no apparent effect on the effector system; contact allergy could 
be elicited normally. However, C. paruum injected in a high 
dose shortly before sensitization will also suppress contact 
allergy as shown in table I and in the previous communication 
[8]. It may therefore be assumed that C. parvum induced 
inhibition will suppress T-helper and T-suppressor cells, how-
ever, T-suppressor cells seem to be more sensitive to this 
mechanism. 
An alternate explanation of the C. paruum mediated "en-
hancement" of contact reactivity in animals tolerated by 
DNBS03 or receiving spleen cells from tolerated animals other 
than suppressor T -cell inhibition should be considered. C. par-
uum could induce specific or unspecific stimulator or effector 
lymphocytes which will mask the suppressive effect of 
DNBS03-induced suppressor T-cells. However, the results ob-
tained in the transfer experiments would argue against such an 
assumption: the kind of test used demonstrates suppressor cells 
(11]; effector cells cannot be demonstrated in spleen cells from 
tolerated animals in an effector cell test (DNFB challenge 
immediately after spleen cell transfer [Knop, unpublished ob-
servation]). Our present knowledge therefore, would support 
the idea that C. parvum in this model of tolerance induction by 
DNBS03 inhibits T suppressor cell induction and/or functional 
expression. 
The mechanism of the suppressor cell inactivation has to be 
analyzed, however, it may be speculated that this phenomenon 
is associated with an activation of the monocytic-phagocytic 
system. C. parvum injected i.v. or i.p. activates macrophages 
which in turn suppress several lymphocyte responses [14] such 
as the generation of cytotoxic lymphocytes [15] or concanavalin 
A-induced lymphocyte proliferation [16]. Such activated mac-
rophages produce a number of lymphocyte suppressive factors 
such as interferon [17] low-molecular weight inhibitors [18] and 
prostaglandins [19]. However, alternate mechanisms may be 
envisaged. 
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